Biphasic modulation of cocaine-induced conditioned place preference through inhibition of histone acetyltransferase and histone deacetylase.
OBJECTIVE
To examine the causative relationship between aberrant histone acetylation changes and cocaine-induced reward.


METHODS
Male Sprague-Dawley rats (n=160) were tested by conditioned place preference (CPP) procedure, to evaluate the effects of inhibitors of histone deacetylase (HDAC) and histone acetyltransferase (HAT) on the conditioned effects of cocaine. Conditioning sessions were conducted twice daily for 2-4 days. For each conditioning session, rats were injected with either HDAC (or HAT) inhibitors or saline in home cages, followed by cocaine (intraperitoneally [ip]) or saline (ip) 30 minutes later, and then immediately confined for 50 minutes in the cue-specific chamber. On the day following the last conditioning session, the rats were tested for place preference for 15 minutes. The present study was carried out at the Department of Pharmacology of Jiaxing University, Jiaxing, Zhejiang, and Pharmacology Research Center of Fudan University, Shanghai, China between October 2007 and January 2009.


RESULTS
Our results showed that pretreatment with HDAC inhibitor (sodium butyrate), potentiated cocaine-induced CPP, but did not itself lead to conditioned preferences, or aversions. On the contrary, rats pretreated with curcumin (HAT inhibitor) markedly inhibited cocaine-induced CPP, but did not itself lead to conditioned preferences or aversions.


CONCLUSIONS
Histone modifications may be an important mechanism that underlies conditioned effects of cocaine. Moreover, HAT may be a potential therapeutic target for cocaine addiction.
Hui
Bin
B
Department of Pharmacology, College of Medicine, Jiaxing University, PO Box 314001, Jiaxing, Zhejiang, China. huibzh@yahoo.com.cn
Wang
Wei
W
Li
Jing
J
D000107:Acetylation; D000818:Animals; D016739:Behavior, Addictive / Q000201:enzymology* / Q000235:genetics; D019970:Cocaine-Related Disorders / Q000201:enzymology* / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D051548:Histone Acetyltransferases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006655:Histone Deacetylases / Q000187:drug effects / Q000378:metabolism*; D006657:Histones / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley
D004791:Enzyme Inhibitors; D006657:Histones; D051548:Histone Acetyltransferases; D006655:Histone Deacetylases